Multiparametric MRI detected increased risk of MASH or advanced fibrosis in over half of MASLD patients classified as low risk by FIB-4. Early use of multiparametric MRI could identify at-risk patients, particularly women and those with diabetes, enabling timely intervention and better disease management compared to current guideline-based risk stratification.